nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.231	0.607	CbGbCtD
Pentobarbital—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0496	0.131	CbGbCtD
Pentobarbital—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0461	0.121	CbGbCtD
Pentobarbital—CHRNA4—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0412	0.226	CbGeAlD
Pentobarbital—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0212	0.0557	CbGbCtD
Pentobarbital—CHRNA4—cochlea—peripheral nervous system neoplasm	0.0209	0.115	CbGeAlD
Pentobarbital—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0194	0.051	CbGbCtD
Pentobarbital—CNS depression NOS—Isotretinoin—peripheral nervous system neoplasm	0.0155	0.0355	CcSEcCtD
Pentobarbital—CNS depression NOS—Tretinoin—peripheral nervous system neoplasm	0.0155	0.0355	CcSEcCtD
Pentobarbital—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0132	0.0348	CbGbCtD
Pentobarbital—CNS depression NOS—Alitretinoin—peripheral nervous system neoplasm	0.0118	0.0269	CcSEcCtD
Pentobarbital—GRIA2—ganglion—peripheral nervous system neoplasm	0.0114	0.0627	CbGeAlD
Pentobarbital—GRIK2—nerve—peripheral nervous system neoplasm	0.0104	0.0573	CbGeAlD
Pentobarbital—GRIK2—ganglion—peripheral nervous system neoplasm	0.0103	0.0566	CbGeAlD
Pentobarbital—Hypoxia—Tretinoin—peripheral nervous system neoplasm	0.01	0.0229	CcSEcCtD
Pentobarbital—Hypoxia—Isotretinoin—peripheral nervous system neoplasm	0.01	0.0229	CcSEcCtD
Pentobarbital—CHRNA7—ganglion—peripheral nervous system neoplasm	0.00841	0.0461	CbGeAlD
Pentobarbital—CHRNA4—nerve—peripheral nervous system neoplasm	0.0084	0.0461	CbGeAlD
Pentobarbital—CHRNA4—ganglion—peripheral nervous system neoplasm	0.00829	0.0455	CbGeAlD
Pentobarbital—Hypoxia—Alitretinoin—peripheral nervous system neoplasm	0.00759	0.0174	CcSEcCtD
Pentobarbital—GABRA2—ganglion—peripheral nervous system neoplasm	0.00742	0.0407	CbGeAlD
Pentobarbital—Respiratory failure—Topotecan—peripheral nervous system neoplasm	0.00653	0.0149	CcSEcCtD
Pentobarbital—Respiratory failure—Tretinoin—peripheral nervous system neoplasm	0.00648	0.0148	CcSEcCtD
Pentobarbital—Respiratory failure—Isotretinoin—peripheral nervous system neoplasm	0.00648	0.0148	CcSEcCtD
Pentobarbital—Hepatocellular injury—Tretinoin—peripheral nervous system neoplasm	0.00637	0.0145	CcSEcCtD
Pentobarbital—Hepatocellular injury—Isotretinoin—peripheral nervous system neoplasm	0.00637	0.0145	CcSEcCtD
Pentobarbital—Injection site reaction—Isotretinoin—peripheral nervous system neoplasm	0.00633	0.0145	CcSEcCtD
Pentobarbital—Injection site reaction—Tretinoin—peripheral nervous system neoplasm	0.00633	0.0145	CcSEcCtD
Pentobarbital—Hepatocellular injury—Melphalan—peripheral nervous system neoplasm	0.00628	0.0144	CcSEcCtD
Pentobarbital—Injection site reaction—Melphalan—peripheral nervous system neoplasm	0.00625	0.0143	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.00615	0.014	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Tretinoin—peripheral nervous system neoplasm	0.00615	0.014	CcSEcCtD
Pentobarbital—GRIA2—brainstem—peripheral nervous system neoplasm	0.00496	0.0272	CbGeAlD
Pentobarbital—Respiratory failure—Alitretinoin—peripheral nervous system neoplasm	0.00491	0.0112	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Isotretinoin—peripheral nervous system neoplasm	0.0049	0.0112	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Tretinoin—peripheral nervous system neoplasm	0.0049	0.0112	CcSEcCtD
Pentobarbital—Liver injury—Cisplatin—peripheral nervous system neoplasm	0.00488	0.0112	CcSEcCtD
Pentobarbital—Hepatocellular injury—Alitretinoin—peripheral nervous system neoplasm	0.00482	0.011	CcSEcCtD
Pentobarbital—GABRA6—brainstem—peripheral nervous system neoplasm	0.0048	0.0263	CbGeAlD
Pentobarbital—Injection site reaction—Alitretinoin—peripheral nervous system neoplasm	0.0048	0.011	CcSEcCtD
Pentobarbital—Respiratory failure—Vincristine—peripheral nervous system neoplasm	0.00473	0.0108	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00466	0.0106	CcSEcCtD
Pentobarbital—GRIK2—brainstem—peripheral nervous system neoplasm	0.00449	0.0246	CbGeAlD
Pentobarbital—Apnoea—Etoposide—peripheral nervous system neoplasm	0.00444	0.0102	CcSEcCtD
Pentobarbital—Hepatocellular injury—Cisplatin—peripheral nervous system neoplasm	0.00411	0.00939	CcSEcCtD
Pentobarbital—GABRG2—trigeminal ganglion—peripheral nervous system neoplasm	0.00399	0.0219	CbGeAlD
Pentobarbital—Dermatitis exfoliative—Alitretinoin—peripheral nervous system neoplasm	0.00371	0.00848	CcSEcCtD
Pentobarbital—CHRNA4—brainstem—peripheral nervous system neoplasm	0.0036	0.0198	CbGeAlD
Pentobarbital—GABRB2—brainstem—peripheral nervous system neoplasm	0.00353	0.0194	CbGeAlD
Pentobarbital—GABRA2—brainstem—peripheral nervous system neoplasm	0.00323	0.0177	CbGeAlD
Pentobarbital—Hallucination—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00727	CcSEcCtD
Pentobarbital—Hallucination—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00727	CcSEcCtD
Pentobarbital—Ataxia—Vincristine—peripheral nervous system neoplasm	0.00317	0.00725	CcSEcCtD
Pentobarbital—GABRA1—brainstem—peripheral nervous system neoplasm	0.00312	0.0171	CbGeAlD
Pentobarbital—GABRB3—trigeminal ganglion—peripheral nervous system neoplasm	0.00306	0.0168	CbGeAlD
Pentobarbital—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00273	0.00624	CcSEcCtD
Pentobarbital—Tension—Tretinoin—peripheral nervous system neoplasm	0.00273	0.00624	CcSEcCtD
Pentobarbital—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.0027	0.00618	CcSEcCtD
Pentobarbital—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.0027	0.00618	CcSEcCtD
Pentobarbital—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00256	0.00586	CcSEcCtD
Pentobarbital—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00256	0.00584	CcSEcCtD
Pentobarbital—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00256	0.00584	CcSEcCtD
Pentobarbital—Liver injury—Epirubicin—peripheral nervous system neoplasm	0.00251	0.00573	CcSEcCtD
Pentobarbital—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.0025	0.0057	CcSEcCtD
Pentobarbital—Syncope—Tretinoin—peripheral nervous system neoplasm	0.0025	0.0057	CcSEcCtD
Pentobarbital—GRIA2—cerebellum—peripheral nervous system neoplasm	0.00245	0.0134	CbGeAlD
Pentobarbital—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.00245	0.00559	CcSEcCtD
Pentobarbital—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.00245	0.00559	CcSEcCtD
Pentobarbital—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00551	CcSEcCtD
Pentobarbital—GABRA6—cerebellum—peripheral nervous system neoplasm	0.00236	0.013	CbGeAlD
Pentobarbital—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00236	0.0054	CcSEcCtD
Pentobarbital—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00236	0.0054	CcSEcCtD
Pentobarbital—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00232	0.00531	CcSEcCtD
Pentobarbital—Liver injury—Doxorubicin—peripheral nervous system neoplasm	0.00232	0.0053	CcSEcCtD
Pentobarbital—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00229	0.00523	CcSEcCtD
Pentobarbital—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00229	0.00523	CcSEcCtD
Pentobarbital—Shock—Tretinoin—peripheral nervous system neoplasm	0.00223	0.00511	CcSEcCtD
Pentobarbital—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00223	0.00511	CcSEcCtD
Pentobarbital—GRIK2—cerebellum—peripheral nervous system neoplasm	0.00221	0.0121	CbGeAlD
Pentobarbital—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00212	0.00485	CcSEcCtD
Pentobarbital—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00212	0.00485	CcSEcCtD
Pentobarbital—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.00211	0.00482	CcSEcCtD
Pentobarbital—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.0021	0.0048	CcSEcCtD
Pentobarbital—Injection site reaction—Epirubicin—peripheral nervous system neoplasm	0.0021	0.0048	CcSEcCtD
Pentobarbital—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00209	0.00479	CcSEcCtD
Pentobarbital—GABRA4—cerebellum—peripheral nervous system neoplasm	0.00208	0.0114	CbGeAlD
Pentobarbital—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00207	0.00473	CcSEcCtD
Pentobarbital—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00205	0.00468	CcSEcCtD
Pentobarbital—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00461	CcSEcCtD
Pentobarbital—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00461	CcSEcCtD
Pentobarbital—Constipation—Topotecan—peripheral nervous system neoplasm	0.00196	0.00447	CcSEcCtD
Pentobarbital—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.00195	0.00446	CcSEcCtD
Pentobarbital—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00194	0.00444	CcSEcCtD
Pentobarbital—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00194	0.00444	CcSEcCtD
Pentobarbital—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.00194	0.00444	CcSEcCtD
Pentobarbital—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00194	0.00443	CcSEcCtD
Pentobarbital—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00189	0.00432	CcSEcCtD
Pentobarbital—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00189	0.00431	CcSEcCtD
Pentobarbital—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00187	0.00428	CcSEcCtD
Pentobarbital—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00187	0.00428	CcSEcCtD
Pentobarbital—Agitation—Vincristine—peripheral nervous system neoplasm	0.00187	0.00427	CcSEcCtD
Pentobarbital—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00424	CcSEcCtD
Pentobarbital—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00181	0.00414	CcSEcCtD
Pentobarbital—CYP2A6—cerebellum—peripheral nervous system neoplasm	0.0018	0.00988	CbGeAlD
Pentobarbital—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.0018	0.0041	CcSEcCtD
Pentobarbital—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.0018	0.0041	CcSEcCtD
Pentobarbital—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00179	0.00409	CcSEcCtD
Pentobarbital—CHRNA4—cerebellum—peripheral nervous system neoplasm	0.00178	0.00975	CbGeAlD
Pentobarbital—GABRG2—cerebellum—peripheral nervous system neoplasm	0.00174	0.00955	CbGeAlD
Pentobarbital—GABRB2—cerebellum—peripheral nervous system neoplasm	0.00174	0.00955	CbGeAlD
Pentobarbital—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00174	0.00397	CcSEcCtD
Pentobarbital—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00387	CcSEcCtD
Pentobarbital—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00169	0.00385	CcSEcCtD
Pentobarbital—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00167	0.00382	CcSEcCtD
Pentobarbital—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00167	0.00382	CcSEcCtD
Pentobarbital—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00165	0.00377	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.00162	0.00371	CcSEcCtD
Pentobarbital—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00161	0.00368	CcSEcCtD
Pentobarbital—GABRA2—cerebellum—peripheral nervous system neoplasm	0.00159	0.00873	CbGeAlD
Pentobarbital—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00155	0.00354	CcSEcCtD
Pentobarbital—GABRA1—cerebellum—peripheral nervous system neoplasm	0.00154	0.00844	CbGeAlD
Pentobarbital—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.0035	CcSEcCtD
Pentobarbital—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00153	0.0035	CcSEcCtD
Pentobarbital—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00348	CcSEcCtD
Pentobarbital—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00151	0.00346	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.00343	CcSEcCtD
Pentobarbital—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0015	0.00343	CcSEcCtD
Pentobarbital—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.00343	CcSEcCtD
Pentobarbital—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00336	CcSEcCtD
Pentobarbital—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00147	0.00335	CcSEcCtD
Pentobarbital—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00146	0.00333	CcSEcCtD
Pentobarbital—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00145	0.00331	CcSEcCtD
Pentobarbital—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00144	0.0033	CcSEcCtD
Pentobarbital—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00144	0.0033	CcSEcCtD
Pentobarbital—Rash—Topotecan—peripheral nervous system neoplasm	0.00144	0.0033	CcSEcCtD
Pentobarbital—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00144	0.0033	CcSEcCtD
Pentobarbital—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00329	CcSEcCtD
Pentobarbital—Headache—Topotecan—peripheral nervous system neoplasm	0.00143	0.00328	CcSEcCtD
Pentobarbital—Rash—Tretinoin—peripheral nervous system neoplasm	0.00143	0.00327	CcSEcCtD
Pentobarbital—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00143	0.00327	CcSEcCtD
Pentobarbital—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00143	0.00327	CcSEcCtD
Pentobarbital—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00143	0.00327	CcSEcCtD
Pentobarbital—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00143	0.00326	CcSEcCtD
Pentobarbital—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00142	0.00325	CcSEcCtD
Pentobarbital—Headache—Tretinoin—peripheral nervous system neoplasm	0.00142	0.00325	CcSEcCtD
Pentobarbital—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00324	CcSEcCtD
Pentobarbital—Constipation—Vincristine—peripheral nervous system neoplasm	0.00142	0.00324	CcSEcCtD
Pentobarbital—Rash—Melphalan—peripheral nervous system neoplasm	0.00141	0.00323	CcSEcCtD
Pentobarbital—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00141	0.00323	CcSEcCtD
Pentobarbital—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00137	0.00313	CcSEcCtD
Pentobarbital—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00137	0.00313	CcSEcCtD
Pentobarbital—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00311	CcSEcCtD
Pentobarbital—Nausea—Topotecan—peripheral nervous system neoplasm	0.00136	0.00311	CcSEcCtD
Pentobarbital—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00135	0.0031	CcSEcCtD
Pentobarbital—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00135	0.00308	CcSEcCtD
Pentobarbital—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00135	0.00308	CcSEcCtD
Pentobarbital—GABRB3—cerebellum—peripheral nervous system neoplasm	0.00134	0.00734	CbGeAlD
Pentobarbital—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00305	CcSEcCtD
Pentobarbital—Nausea—Melphalan—peripheral nervous system neoplasm	0.00133	0.00304	CcSEcCtD
Pentobarbital—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00131	0.003	CcSEcCtD
Pentobarbital—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.0029	CcSEcCtD
Pentobarbital—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00126	0.00287	CcSEcCtD
Pentobarbital—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00122	0.00279	CcSEcCtD
Pentobarbital—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00276	CcSEcCtD
Pentobarbital—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00119	0.00273	CcSEcCtD
Pentobarbital—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00118	0.0027	CcSEcCtD
Pentobarbital—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00267	CcSEcCtD
Pentobarbital—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00265	CcSEcCtD
Pentobarbital—Constipation—Etoposide—peripheral nervous system neoplasm	0.00115	0.00263	CcSEcCtD
Pentobarbital—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.0026	CcSEcCtD
Pentobarbital—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00111	0.00253	CcSEcCtD
Pentobarbital—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00252	CcSEcCtD
Pentobarbital—Dizziness—Vincristine—peripheral nervous system neoplasm	0.0011	0.00251	CcSEcCtD
Pentobarbital—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.0025	CcSEcCtD
Pentobarbital—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00248	CcSEcCtD
Pentobarbital—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00248	CcSEcCtD
Pentobarbital—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00247	CcSEcCtD
Pentobarbital—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00247	CcSEcCtD
Pentobarbital—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00246	CcSEcCtD
Pentobarbital—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00106	0.00243	CcSEcCtD
Pentobarbital—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00105	0.00241	CcSEcCtD
Pentobarbital—Rash—Vincristine—peripheral nervous system neoplasm	0.00105	0.00239	CcSEcCtD
Pentobarbital—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00104	0.00239	CcSEcCtD
Pentobarbital—Headache—Vincristine—peripheral nervous system neoplasm	0.00104	0.00237	CcSEcCtD
Pentobarbital—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00234	CcSEcCtD
Pentobarbital—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000998	0.00228	CcSEcCtD
Pentobarbital—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00099	0.00226	CcSEcCtD
Pentobarbital—Nausea—Vincristine—peripheral nervous system neoplasm	0.000985	0.00225	CcSEcCtD
Pentobarbital—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000932	0.00213	CcSEcCtD
Pentobarbital—Rash—Cisplatin—peripheral nervous system neoplasm	0.000925	0.00211	CcSEcCtD
Pentobarbital—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000924	0.00211	CcSEcCtD
Pentobarbital—Tension—Epirubicin—peripheral nervous system neoplasm	0.000905	0.00207	CcSEcCtD
Pentobarbital—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000896	0.00205	CcSEcCtD
Pentobarbital—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000888	0.00203	CcSEcCtD
Pentobarbital—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000871	0.00199	CcSEcCtD
Pentobarbital—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000854	0.00195	CcSEcCtD
Pentobarbital—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000848	0.00194	CcSEcCtD
Pentobarbital—Rash—Etoposide—peripheral nervous system neoplasm	0.000847	0.00194	CcSEcCtD
Pentobarbital—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000846	0.00193	CcSEcCtD
Pentobarbital—Headache—Etoposide—peripheral nervous system neoplasm	0.000842	0.00192	CcSEcCtD
Pentobarbital—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000838	0.00191	CcSEcCtD
Pentobarbital—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000829	0.0019	CcSEcCtD
Pentobarbital—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000827	0.00189	CcSEcCtD
Pentobarbital—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000811	0.00185	CcSEcCtD
Pentobarbital—Nausea—Etoposide—peripheral nervous system neoplasm	0.000798	0.00182	CcSEcCtD
Pentobarbital—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000785	0.00179	CcSEcCtD
Pentobarbital—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000783	0.00179	CcSEcCtD
Pentobarbital—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000766	0.00175	CcSEcCtD
Pentobarbital—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000759	0.00174	CcSEcCtD
Pentobarbital—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.00172	CcSEcCtD
Pentobarbital—Shock—Epirubicin—peripheral nervous system neoplasm	0.000741	0.00169	CcSEcCtD
Pentobarbital—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000724	0.00166	CcSEcCtD
Pentobarbital—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000704	0.00161	CcSEcCtD
Pentobarbital—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000703	0.00161	CcSEcCtD
Pentobarbital—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000686	0.00157	CcSEcCtD
Pentobarbital—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000669	0.00153	CcSEcCtD
Pentobarbital—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000651	0.00149	CcSEcCtD
Pentobarbital—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000644	0.00147	CcSEcCtD
Pentobarbital—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000621	0.00142	CcSEcCtD
Pentobarbital—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000619	0.00142	CcSEcCtD
Pentobarbital—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000596	0.00136	CcSEcCtD
Pentobarbital—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000595	0.00136	CcSEcCtD
Pentobarbital—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.00131	CcSEcCtD
Pentobarbital—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000555	0.00127	CcSEcCtD
Pentobarbital—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.00126	CcSEcCtD
Pentobarbital—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.00117	CcSEcCtD
Pentobarbital—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000498	0.00114	CcSEcCtD
Pentobarbital—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000479	0.00109	CcSEcCtD
Pentobarbital—Rash—Epirubicin—peripheral nervous system neoplasm	0.000475	0.00109	CcSEcCtD
Pentobarbital—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000474	0.00108	CcSEcCtD
Pentobarbital—Headache—Epirubicin—peripheral nervous system neoplasm	0.000472	0.00108	CcSEcCtD
Pentobarbital—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.00105	CcSEcCtD
Pentobarbital—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000447	0.00102	CcSEcCtD
Pentobarbital—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.00101	CcSEcCtD
Pentobarbital—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.001	CcSEcCtD
Pentobarbital—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.001	CcSEcCtD
Pentobarbital—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000998	CcSEcCtD
Pentobarbital—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000946	CcSEcCtD
